Abstracts Archive - Page 137 of 1683 - ATC Abstracts

2022 American Transplant Congress
Hepatitis C (HCV) Positive Recipients and/or Donors in Pancreas Transplantation – A Registry Analysis
A. C. Gruessner, R. Gruessner
SUNY Downstate Medical Center, Brooklyn, NY
*Purpose: Pancreas transplantation (PT) is the best long-term option for patients with labile diabetes and end-stage-renal disease. The mortality on the waitlist is high; patients…
2022 American Transplant Congress
Phenytoin To Expedite Sirolimus & Tacrolimus Elimination: A Case Report
A. Lemke, B. A. Boilson, R. Razonable, S. A. Bernard
Mayo Clinic, Rochester, MN
*Purpose: Sirolimus (SIR), a mammalian target of rapamycin inhibitor (mTORi), may be used with or without a calcineurin inhibitor after heart transplant (HT). The anti-proliferative…
2022 American Transplant Congress
Belatacept-Based Maintenance Immunosuppression Promoted Long-Term Antibody-Mediated Rejection Free Graft Survival After Desensitization in Sensitized Multiparous Female Recipients
M. Manook, I. Anwar, R. Schmitz, Z. Fitch, J. Yoon, A. Jackson, J. Kwun, S. Knechtle
Duke Transplant Center, Durham, NC
*Purpose: Amongst sensitized patients awaiting a transplant, females are disproportionately represented. To date, nonhuman primate (NHP) models of transplantation have relied on male animals, sensitized…
2022 American Transplant Congress
Telemedicine Services for Living Kidney Donation: A U.S. Survey of Multidisciplinary Providers
F. Al Ammary¹, J. Motter¹, H. Sung¹, K. Lentine², A. Sharfuddin³, V. Kumar⁴, A. Yadav⁵, M. Doshi⁶, S. Virmani⁷, B. Concepcion⁸, T. Grace⁹, C. Sidoti¹, M. Y. Jon³, A. Muzaale¹, J. Wolf¹⁰
¹Johns Hopkins, Baltimore, MD, ²Saint Louis University, St. Louis, MO, ³Indiana University, Indianapolis, IN, ⁴University of Alabama, Birmingham, AL, ⁵Thomas Jefferson, Philadelphia, MD, ⁶University of Michigan, Ann Arbor, MD, ⁷Yale, New Haven, CT, ⁸Vanderbilt, Nashville, TN, ⁹Wake Forest, Winston-Salem, NC, ¹⁰Piedmont, Atlanta, GA
*Purpose: Individuals considering living kidney donation face geographic, financial, and logistical challenges. Telemedicine has the potential to facilitate care delivery/coordination for donors. We aimed to…
2022 American Transplant Congress
Outcomes and Complications of Covid-19 in Pediatric Solid Organ Transplant Patients
L. Ott, P. Scalise, B. Kimball, A. G. Cuenca
Department of Surgery, Boston Children's Hospital, Boston, MA
*Purpose: The purpose of the study was to examine the clinical course, outcomes, and complications of COVID-19 in pediatric solid organ transplant patients from a…
2022 American Transplant Congress
Establishment of an In Vitro Assay to Evaluate Indirect T-cell Allo-Response Using Donor PBMC-Pulsed Dendritic Cells
K. Iwasaki¹, T. Tomosugi², T. Sekiya³, H. Hamana⁴, Y. Miwa¹, K. Futamura², M. Okada², T. Hiramitsu², N. Goto², S. Narumi², Y. Watarai², H. Kishi⁴, M. Okumura⁵, S. Ashimine⁵, K. Ishiyama⁵, T. Kobayashi⁵
¹Department of Kidney Diseases and Transplant Immunology, Aichi Medical University School of Medicine, Nagakute, Japan, ²Department of Transplant Surgery, Japanese Red Cross Aichi Medical Center Nagoya Daini Hospital, Nagoya, Japan, ³Department of Immune Regulation, The Research Center for Hepatitis and Immunology, Ichikawa, Japan, ⁴Department of Immunology, University of Toyama, Toyama, Japan, ⁵Department of Renal Transplant Surgery, Aichi Medical University School of Medicine, Nagakute, Japan
*Purpose: Conventional MLR-based methods which evaluate donor-specific immune response via direct T-cell recognition pathway have been reported to be useful in predicting acute TCMR. However,…
2022 American Transplant Congress
A Intention-to-Treat Analysis of 881 Consecutively Waitlisted Patients to Develop a Survival Benefit Model for Hepatocellular Carcinoma Liver Transplant Candidates
B. V. Tran¹, W. Lapisatepun¹, W. Dumronggittigule¹, D. Markovic², Y. Lee¹, F. Kaldas¹, D. Farmer¹, R. Busuttil¹, V. Agopian¹
¹Department of Surgery, University of California Los Angeles, Los Angeles, CA, ²Department of Medicine, Statistics Core, University of California Los Angeles, Los Angeles, CA
*Purpose: The current liver transplantation (LT) selection paradigm for hepatocellular carcinoma (HCC) patients ignores the variable risks of waitlist dropout and post-LT recurrence/death, with the…
2022 American Transplant Congress
Experience with Covid-19 Infection and Vaccination in Combined Kidney/HSCT Recipients
M. Gibson¹, D. Belshe¹, G. Gregory¹, S. Tanna¹, M. Ison¹, S. Ildstad², J. R. Leventhal¹
¹Northwestern University, Chicago, IL, ²University of Louisville, Louisville, KY
*Purpose: Kidney transplant(KTx) recipients are at increased risk of COVID-19 related complications. KTx pts who have undergone therapy to induce tolerance are a unique cohort…
2022 American Transplant Congress
Cryptococcal Meningitis Presenting as SIADH in a Heart Transplant Recipient
D. Blake, M. Ibrahim, E. Hamad, V. Rakita, J. Hoosain, H. Clauss
Temple University Hospital, Philadelphia, PA
*Purpose: Cryptococcal meningitis is a potentially fatal invasive fungal infection in solid organ transplant recipients. Meningoencephalitis is the most common clinical manifestation of cryptococcal infection.…
2022 American Transplant Congress
Antibody Response to Sars- Cov -2 Mrna Vaccine in Kidney Transplant Recipients
R. Mohamed Abdul Rahman, M. Alkadi, E. Abuhelaiqa, M. Jarman, A. Nauman, O. Fituri, M. Asim, A. Hamad, H. Tohid, P. Coyle, L. Abu Raddad, H. Al-Malki
Nephrology, Hamad Medical Corporation, Doha, Qatar
*Purpose: Kidney transplant recipients are vulnerable to develop severe form of COVID19 Infection. Although severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mRNA vaccine has significantly…